Calciphylaxis and its diagnosis: A review

Deepak Baby, Meenakshi Upadhyay, M Derick Joseph, Swati Joshi Asopa, Basanta Kumar Choudhury, Jagadish Prasad Rajguru, Shivangi Gupta, Deepak Baby, Meenakshi Upadhyay, M Derick Joseph, Swati Joshi Asopa, Basanta Kumar Choudhury, Jagadish Prasad Rajguru, Shivangi Gupta

Abstract

Calciphylaxis also known as Calcific uremic arteriolopathy (CUA), is a rare fatal complication usually associated with end-stage renal disease (ESRD). It is characterized by skin ulceration and necrosis leading to significant pain. The disease calciphylaxis is pathological state resulting in accumulation of calcium content in medial wall of small blood vessels along with the fibrotic changes in intima. The aetiopathogenesis of this disease, small vessel vasculopathy, remains complicated, and unclear. It is believed that development of calciphylaxis depends on medial calcification, intimal fibrosis of arterioles and thrombotic occlusion. The disease is rare, life-threatening medical condition that occurs mostly in population with kidney disease or in patients on dialysis. Skin biopsy and radiographic features are helpful in the diagnosis of calciphylaxis, but negative results do not necessarily exclude the diagnosis. This article highlights steps undertaking in the diagnosis of calciphylaxis.

Keywords: Calciphylaxis; calcium; small blood vessels.

Conflict of interest statement

There is no conflict of interest.

Copyright: © 2019 Journal of Family Medicine and Primary Care.

References

    1. Milas M, Bush RL, Lin P, Brown K, Mackay G, Lumsden A, et al. Calciphylaxis and nonhealing wounds: The role of the vascular surgeon in a multidisciplinary treatment. J Vas Surg. 2003;37:501–7.
    1. Bryant J, White W. A case of calcification of the arteries and obloterative endarterities, associated with hydronephrosis, in a child aged six months. Guys Hosp Rep. 1898;55:17–20.
    1. Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology. 1962;71:554–8.
    1. Selye H. The dermatologic implications of stress and calciphylaxis. J Invest Dermatol. 1962;39:259–75.
    1. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int. 2002;61:2210–7.
    1. Ketteler M. Case report. N Engl J Med. 2001;345:1119–24.
    1. Hussein MR, Ali HO, Abdulwahed SR, Argoby Y, Tobeigei FH. Calciphylaxis cutis: A case report and review of lilerature. Exp Mol Pathol. 2009;86:134–5.
    1. Fernandez M, Morales E, Gutierrez E, Polanco N, Hernandez E, Merida E, et al. Calciphylaxis: Beyond CKD-MBD. Nefrologia. 2017;37:501–7.
    1. Trost O, Kadlub N, Trouilloud P, Malka G, Danino A. Calciphylaxis: A severe but unrecognised complication in end-stage renal disease patients. A review of 2 cases. Ann Chir Plast Esthet. 2005;50:746–50.
    1. Imam AA, Mattoo TK, Kapur G, Bloom DA, Valentini RP. Calciphylaxis in pediatric end-stage renal disease. Pediatr Nephrol. 2005;20:1776–80.
    1. Slough S, Servilla KS, Harford AM, Konstantinov KN, Harris A, Tzamaloukas AH. Association between calciphylaxis and inflammation in two patients on chronic dialysis. Adv Perit Dial. 2006;22:171–4.
    1. Sowers K, Hayden M. Calcific uremic arteriopathy: Pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev. 2010;3:109–21.
    1. Bhambri S, Bhambri A, Dell Rosso JQ. Calciphylaxis: A review. J Clin Aesthetic Dermatol. 2008;1:38–41.
    1. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008;19:213–6.
    1. Jeong, Dominguez Calciphylaxis: Controversies in pathogenesis, diagnosis and treatment. Am J Med Sci. 2016;351:217–27.
    1. Wenstedt EFE, Huysentruyt CJ, Konings CJAM. Acenocoumarol as a risk factor for calciphylaxis: A feature clinicians should be aware of. Neth J Med. 2017;75:161–4.
    1. Cucchiari D, Torregrosa JV. Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal. Nefrologia. 2018;38:579–86.
    1. Griethe W, Schmitt R, Jurgensen JS, Bachmann S, Eckardt KU, Schindler R. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol. 2003;16:728–32.
    1. Fares I, Bouattar T, Kone HM, Benzouina H, Benbella M, Ouzeddoun N, et al. Calciphylaxis: Successful management of a rare complication of chronic kidney disease in two patients. Case Rep Nephrol. 2019;2019:1–6.
    1. Brewster U. Dermatological disease in patients with CDK. Am J Kidney Dis. 2008;51:331–44.
    1. Dauden E, Onate M. Calciphylaxis. Dermatol Clin. 2008;26:557–68.
    1. Nazarian R, Cott EV, Zembowiez A, Duncan L. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009;61:325–32.
    1. Rogers N, Teubner D, Coates P. Calcific uremic arteriolopathy: Advances in pathogenesis and treatment. Semin Dial. 2007;20:150–57.
    1. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357–66.
    1. Shmidt E, Murthy NS, Knudsen JM, Weenig RH, Jacobs MA, Starnes AM, et al. Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. J Am Acad Dermatol. 2012;67:1296–301.
    1. Han MM, Pang J, Shinkai K, Franc B, Hawkins R, Aparici CM. Calciphylaxis and bone scintigraphy: Case report with histological confirmation and review of the literature. Ann Nucl Med. 2007;21:235–8.
    1. Chang JJ. Calciphylaxis: Diagnosis, pathogenesis, and treatment. Adv Skin Wound Care. 2019;32:205–15.
    1. Martineau P, Pelletier-Galarneau M, Bazarjani S. The role of bone scintigraphy with single-photon emission computed tomography-computed tomography in the diagnosis and evaluation of calciphylaxis. World J Nucl Med. 2017;16:172–4.
    1. Lloyd WR, Agarwal S, Nigwekar SU, Esmonde-White K, Loder S, Fagan S. Raman spectroscopy for label-free identification of calciphylaxis. J Biomed Opt. 2015;20:80501.
    1. Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, et al. Calciphylaxis: Risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66:133–46.
    1. Angelis M, Wong L, Myers S, Wong L. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery. 1997;122:1083–9.
    1. Rogers N, Coates P. Calcific uraemic arteriolopathy: An update. Curr Opin Nephrol Hypertens. 2008;17:629–34.
    1. Weenig R. Pathogenesis of calciohylaxis: Hans selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008;58:458–71.
    1. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;378:1704.
    1. Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP. Cutaneous calciphylaxis: A retrospective histopathologic evaluation. Am J Dermatopathol. 2013;35:582–6.
    1. Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU. Review: Update on the management of calciphylaxis. QJM. 2019;112:29–34.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa